Business Description
Medicure Inc
NAICS : 325410
SIC : 3741
ISIN : CA58469E4085
Total Employee Number:
22Compare
Compare
Traded in other countries / regions
MPH.CanadaMCUJF.USANGQ1.Germany IPO Date
2004-02-17Description
Medicure Inc is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market and sales to the Retail Public of pharmaceutical products. The Company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and increasing its e-commerce and mail order pharmaceutical business. The Company operates under two segments: the marketing and distribution of commercial products and the operation of a retail and mail order pharmacy. It generates the majority of its revenue from the Retail and Mail Order Pharmacy segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.92 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.2 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -3.41 | |||||
Beneish M-Score | -2.77 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.8 | |||||
3-Year Book Growth Rate | -15.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 58.4 | |||||
9-Day RSI | 65.35 | |||||
14-Day RSI | 63.88 | |||||
3-1 Month Momentum % | -10.05 | |||||
6-1 Month Momentum % | -28.31 | |||||
12-1 Month Momentum % | -23.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.04 | |||||
Quick Ratio | 0.73 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 69.33 | |||||
Days Sales Outstanding | 56.5 | |||||
Days Payable | 174.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | -1.62 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.68 | |||||
Operating Margin % | -21.07 | |||||
Net Margin % | -21.74 | |||||
EBITDA Margin % | -12.54 | |||||
FCF Margin % | -9.73 | |||||
OCF Margin % | -9.73 | |||||
ROE % | -41.89 | |||||
ROA % | -25.55 | |||||
ROIC % | -46.98 | |||||
3-Year ROIIC % | 220.93 | |||||
ROC (Joel Greenblatt) % | -591.98 | |||||
ROCE % | -39.28 | |||||
Years of Profitability over Past 10-Year | 4 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 4.88 | |||||
PS Ratio | 0.35 | |||||
PB Ratio | 0.86 | |||||
Price-to-Tangible-Book | 11.06 | |||||
EV-to-EBIT | -1.54 | |||||
EV-to-EBITDA | -2.58 | |||||
EV-to-Revenue | 0.32 | |||||
EV-to-Forward-Revenue | 0.02 | |||||
EV-to-FCF | -3.33 | |||||
Price-to-GF-Value | 0.72 | |||||
Price-to-Projected-FCF | 0.63 | |||||
Price-to-Median-PS-Value | 0.45 | |||||
Earnings Yield (Greenblatt) % | -64.94 | |||||
FCF Yield % | -28.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MCUJF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicure Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 22.762 | ||
| EPS (TTM) ($) | -0.472 | ||
| Beta | 0.8909 | ||
| 3-Year Sharpe Ratio | -0.04 | ||
| 3-Year Sortino Ratio | -0.05 | ||
| Volatility % | 55.08 | ||
| 14-Day RSI | 63.88 | ||
| 14-Day ATR ($) | 0.012305 | ||
| 20-Day SMA ($) | 0.744282 | ||
| 12-1 Month Momentum % | -23.51 | ||
| 52-Week Range ($) | 0.6746 - 0.9745 | ||
| Shares Outstanding (Mil) | 10.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicure Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicure Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-20 08:30 | In 114 days | ||
| Third quarter earnings results for 2026 | 2026-11-20 | In 113 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-21 08:30 | In 23 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 21 days | ||
| First quarter earnings conference call for 2026 | 2026-05-25 08:30 | 0.80 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-25 | 0.80 (+0.00%) | ||
| General meeting for 2025 | 2026-05-21 | 0.80 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-04-27 08:30 | 0.75 (+0.00%) | ||
| Annual report for 2025 | 2026-04-23 | 0.96 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-04-23 | 0.96 (+0.00%) |
Show
Entries
Medicure Inc Frequently Asked Questions
What is Medicure Inc(MCUJF)'s stock price today?
The current price of MCUJF is $0.81. The 52 week high of MCUJF is $0.97 and 52 week low is $0.67.
When is next earnings date of Medicure Inc(MCUJF)?
The next earnings date of Medicure Inc(MCUJF) is 2026-08-20 Est..
Does Medicure Inc(MCUJF) pay dividends? If so, how much?
Medicure Inc(MCUJF) does not pay dividend.
Guru Commentaries on OTCPK:MCUJF
No articles.
Press Release
Articles on Medicure Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers